FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126502186> ?p ?o ?g. }

• W2126502186 endingPage "347" @default.
• W2126502186 startingPage "336" @default.
• W2126502186 abstract "There is growing recognition that a comprehensive economic assessment of a new health-care intervention at the time of launch requires both a cost-effectiveness analysis (CEA) and a budget impact analysis (BIA). National regulatory agencies such as the National Institute for Health and Clinical Excellence in England and Wales and the Pharmaceutical Benefits Advisory Committee in Australia, as well as managed care organizations in the United States, now require that companies submit estimates of both the cost-effectiveness and the likely impact of the new health-care interventions on national, regional, or local health plan budgets. Although standard methods for performing and presenting the results of CEAs are well accepted, the same progress has not been made for BIAs. The objective of this report is to present guidance on methodologies for those undertaking such analyses or for those reviewing the results of such analyses.The Task Force was appointed with the advice and consent of the Board of Directors of ISPOR. Members were experienced developers or users of budget impact models, worked in academia, industry, and as advisors to governments, and came from several countries in North America, Oceana, Asia, and Europe. The Task Force met to develop core assumptions and an outline before preparing a draft report. They solicited comments on the outline and two drafts from a core group of external reviewers and more broadly from the membership of ISPOR at two ISPOR meetings and via the ISPOR web site.The Task Force recommends that the budget impact of a new health technology should consider the perspective of the specific health-care decision-maker. As such, the BIA should be performed using data that reflect, for a specific health condition, the size and characteristics of the population, the current and new treatment mix, the efficacy and safety of the new and current treatments, and the resource use and costs for the treatments and symptoms as would apply to the population of interest. The Task Force recommends that budget impact analyses be generated as a series of scenario analyses in the same manner that sensitivity analyses would be provided for CEAs. In particular, the input values for the calculation and the specific cost outcomes presented (a scenario) should be specific to a particular decision-maker's population and information needs. Sensitivity analysis should also be in the form of alternative scenarios chosen from the perspective of the decision-maker. The primary data sources for estimating the budget impact should be published clinical trial estimates and comparator studies for efficacy and safety of current and new technologies as well as, where possible, the decision-maker's own population for the other parameter estimates. Suggested default data sources also are recommended. These include the use of published data, well-recognized local or national statistical information and in special circumstances, expert opinion. Finally, the Task Force recommends that the analyst use the simplest design that will generate credible and transparent estimates. If a health condition model is needed for the BIA, it should reflect health outcomes and their related costs in the total affected population for each year after the new intervention is introduced into clinical practice. The model should be consistent with that used for the CEA with regard to clinical and economic assumptions.The BIA is important, along with the CEA, as part of a comprehensive economic evaluation of a new health technology. We propose a framework for creating budget impact models, guidance about the acquisition and use of data to make budget projections and a common reporting format that will promote standardization and transparency. Adherence to these proposed good research practice principles would not necessarily supersede jurisdiction-specific budget impact guidelines, but may support and enhance local recommendations or serve as a starting point for payers wishing to promulgate methodology guidelines." @default.
• W2126502186 created "2016-06-24" @default.
• W2126502186 creator A5001156357 @default.
• W2126502186 creator A5007482776 @default.
• W2126502186 creator A5016786296 @default.
• W2126502186 creator A5025789949 @default.
• W2126502186 creator A5027025101 @default.
• W2126502186 creator A5027695585 @default.
• W2126502186 creator A5032255921 @default.
• W2126502186 creator A5032325756 @default.
• W2126502186 creator A5062818266 @default.
• W2126502186 date "2007-09-01" @default.
• W2126502186 modified "2023-10-06" @default.
• W2126502186 title "Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis" @default.
• W2126502186 cites W154048893 @default.
• W2126502186 cites W157370375 @default.
• W2126502186 cites W185692532 @default.
• W2126502186 cites W1968657982 @default.
• W2126502186 cites W1970325628 @default.
• W2126502186 cites W1981170239 @default.
• W2126502186 cites W2012417087 @default.
• W2126502186 cites W2023897383 @default.
• W2126502186 cites W2026751503 @default.
• W2126502186 cites W2029468610 @default.
• W2126502186 cites W2035509993 @default.
• W2126502186 cites W2045200703 @default.
• W2126502186 cites W2052437363 @default.
• W2126502186 cites W2059506670 @default.
• W2126502186 cites W2060573155 @default.
• W2126502186 cites W2061391567 @default.
• W2126502186 cites W2068234206 @default.
• W2126502186 cites W2070432392 @default.
• W2126502186 cites W2090313520 @default.
• W2126502186 cites W2091286035 @default.
• W2126502186 cites W2103327420 @default.
• W2126502186 cites W2125860587 @default.
• W2126502186 cites W2130154615 @default.
• W2126502186 cites W2131928350 @default.
• W2126502186 cites W2143532751 @default.
• W2126502186 cites W2150712216 @default.
• W2126502186 cites W4299647588 @default.
• W2126502186 cites W2006894970 @default.
• W2126502186 doi "https://doi.org/10.1111/j.1524-4733.2007.00187.x" @default.
• W2126502186 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17888098" @default.
• W2126502186 hasPublicationYear "2007" @default.
• W2126502186 type Work @default.
• W2126502186 sameAs 2126502186 @default.
• W2126502186 citedByCount "553" @default.
• W2126502186 countsByYear W21265021862012 @default.
• W2126502186 countsByYear W21265021862013 @default.
• W2126502186 countsByYear W21265021862014 @default.
• W2126502186 countsByYear W21265021862015 @default.
• W2126502186 countsByYear W21265021862016 @default.
• W2126502186 countsByYear W21265021862017 @default.
• W2126502186 countsByYear W21265021862018 @default.
• W2126502186 countsByYear W21265021862019 @default.
• W2126502186 countsByYear W21265021862020 @default.
• W2126502186 countsByYear W21265021862021 @default.
• W2126502186 countsByYear W21265021862022 @default.
• W2126502186 countsByYear W21265021862023 @default.
• W2126502186 crossrefType "journal-article" @default.
• W2126502186 hasAuthorship W2126502186A5001156357 @default.
• W2126502186 hasAuthorship W2126502186A5007482776 @default.
• W2126502186 hasAuthorship W2126502186A5016786296 @default.
• W2126502186 hasAuthorship W2126502186A5025789949 @default.
• W2126502186 hasAuthorship W2126502186A5027025101 @default.
• W2126502186 hasAuthorship W2126502186A5027695585 @default.
• W2126502186 hasAuthorship W2126502186A5032255921 @default.
• W2126502186 hasAuthorship W2126502186A5032325756 @default.
• W2126502186 hasAuthorship W2126502186A5062818266 @default.
• W2126502186 hasBestOaLocation W21265021861 @default.
• W2126502186 hasConcept C142724271 @default.
• W2126502186 hasConcept C144133560 @default.
• W2126502186 hasConcept C159110408 @default.
• W2126502186 hasConcept C160735492 @default.
• W2126502186 hasConcept C17744445 @default.
• W2126502186 hasConcept C184356942 @default.
• W2126502186 hasConcept C199539241 @default.
• W2126502186 hasConcept C204787440 @default.
• W2126502186 hasConcept C27415008 @default.
• W2126502186 hasConcept C2777352838 @default.
• W2126502186 hasConcept C2780454255 @default.
• W2126502186 hasConcept C2780877353 @default.
• W2126502186 hasConcept C2985871740 @default.
• W2126502186 hasConcept C3116431 @default.
• W2126502186 hasConcept C524218345 @default.
• W2126502186 hasConcept C71924100 @default.
• W2126502186 hasConceptScore W2126502186C142724271 @default.
• W2126502186 hasConceptScore W2126502186C144133560 @default.
• W2126502186 hasConceptScore W2126502186C159110408 @default.
• W2126502186 hasConceptScore W2126502186C160735492 @default.
• W2126502186 hasConceptScore W2126502186C17744445 @default.
• W2126502186 hasConceptScore W2126502186C184356942 @default.
• W2126502186 hasConceptScore W2126502186C199539241 @default.
• W2126502186 hasConceptScore W2126502186C204787440 @default.
• W2126502186 hasConceptScore W2126502186C27415008 @default.
• W2126502186 hasConceptScore W2126502186C2777352838 @default.
• W2126502186 hasConceptScore W2126502186C2780454255 @default.

• next